Table 2.
Tumor type | Mice strain | Implantation site | Engraftment rate | References |
---|---|---|---|---|
Breast cancer | Nude | Subcutaneous | 13% | Marangoni et al., 2007 |
NOD scid | Mammary fat pad | 27% | DeRose et al., 2011 | |
scid/Beige, NSG | Mammary fat pad | 19–21% | Zhang et al., 2013 | |
NOD scid | Humanized mammary fat pad | 13% | Li et al., 2013 | |
| ||||
Colorectal cancer | NOD scid | Subcutaneous | 87% | Bertotti et al., 2011 |
Nude | Subcutaneous | 64% | Julien et al., 2012 | |
Nude | Orthotopic | 89% | Aytes et al., 2012 | |
| ||||
Head and neck cancer (squamous cell carcinoma) | NSG | Subcutaneous | 85% | Kimple et al., 2013 |
Nude | Subcutaneous | 54% | Keysar et al., 2013 | |
| ||||
Medulloblastoma | Rag2 scid | Orthotopic | 52% | Zhao et al., 2012 |
| ||||
Non-small cell lung cancer | NOD scid | Subcutaneous | 25% | Fichtner et al., 2008 |
NOD scid | Renal capsule | 90% | Dong et al., 2010 | |
| ||||
Pancreatic cancer (ductal adenocarcinoma) | Nude | Subcutaneous | 61% | Garrido-Laguna et al., 2011 |
Nude | Orthotopic | 62% | Reyes et al., 1996 | |
ICR scid | Subcutaneous | 67% | Mattie et al., 2013 | |
| ||||
Uveal melanoma | NOD scid | Subcutaneous | 28% | Némati et al., 2010 |